Severe Asthma Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increasing Prevalence of Severe Asthma
   3. Market Restraints
      1. High Cost of Treatment
      2. Limited Awareness and Diagnosis
   4. Market Opportunities
      1. Emergence of Several Biologic Therapies
   5. Market Trends
      1. Personalized Medicine and Biomarker Development
      2. Integration of Digital Health Technologies
5. MARKET SEGMENTATION
   1. By Treatment
      1. Medication
      2. Surgery
   2. By Drugs
      1. Approved Drugs
      2. Off-label Drugs
   3. By Route of Administration
      1. Oral
      2. Injectable
   4. By End- Users
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
   5. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
2. By Key Geographic Regions
   1. North America
      1. United States
      2. Canada
      3. Mexico
   2. Europe
      1. Germany
      2. United Kingdom
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
   3. Asia Pacific
      1. China
      2. Japan
      3. India
      4. Australia
      5. South Korea
      6. Rest of Asia Pacific
   4. Middle East and Africa
      1. GCC
      2. South Africa
      3. Rest of Middle East and Africa
   5. South America
      1. Brazil
      2. Argentina
      3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. 4D Pharma plc
      2. Avalo Therapeutics
      3. AB Pharma
      4. AstraZeneca
      5. Biosion
      6. GlaxoSmithKline
      7. Morphosys
      8. Novartis
      9. Pieris Pharma
      10. Roche
      11. Regeneron Pharmaceutical
      12. Suzhou Connect Biopharmaceuticals
      13. Sanofi
      14. Teva Pharmaceutical
   2. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Severe Asthmamarket?

The global market of Severe Asthma is projected to reach USD 36.18Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Severe Asthmamarket?

The global Severe Asthma market has an estimated annual growth rate of 5.1%. 

Q.3. What are the recent trends of Severe Asthmamarket?

Personalized medicine and biomarker development and integration of digital health technologies are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Severe Asthma?

The major companies profiled in this report include 4D Pharma plc, Avalo Therapeutics, AB Pharma, AstraZeneca, Biosion, GlaxoSmithKline, Morphosys, Novartis, Pieris Pharma, Roche, Regeneron Pharmaceutical, Suzhou Connect Biopharmaceuticals, Sanofi, Teva Pharmaceutical, among others.

Q.5. Which region is estimated to held highest CAGR inSevere Asthmamarket?

North America is estimated to hold biggest share in the market for Severe Asthma.